Physician profile
George Rector
NPI 1295712081
$1,298.48
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $239 · 2021: $471 · 2022: $62.10.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.36 | 2019-2021 | |
| Minerva Surgical, INC | $168.96 | 2019-2021 | |
| Daiichi Sankyo INC. | $166.37 | 2019-2021 | |
| Astellas Pharma US INC | $112.08 | 2019-2021 | |
| Amgen INC. | $94.56 | 2019-2021 | |
| Myovant Sciences INC. | $77.17 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $58.48 | 2019-2021 | |
| Exeltis, USA INC. | $57.36 | 2021 | |
| Amag Pharmaceuticals, INC. | $49.50 | 2019 | |
| Therapeuticsmd, INC. | $41.32 | 2019-2021 | |
| Pfizer INC. | $37.30 | 2019-2021 | |
| Evofem Biosciences, INC. | $37.07 | 2021 | |
| Novo Nordisk INC | $34.93 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.53 | 2019 | |
| Vertical Pharmaceuticals, LLC | $28.80 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $22.62 | 2019-2020 | |
| Duchesnay USA Incorporated | $18.87 | 2019 | |
| Teleflex LLC | $16.12 | 2020 | |
| Urovant Sciences INC | $15.59 | 2022 | |
| Hologic Sales and Service, LLC | $13.74 | 2021 | |
| Organon LLC | $12.02 | 2022 | |
| Glaxosmithkline, LLC. | $11.72 | 2019 | |
| Allergan, INC. | $11.01 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Rector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.